H.C. Wainwright & Co., LLC Announces Investment Opinion on Heat Biologics, Inc.

H.C. Wainwright & Co., LLC announced Dr. Reni Benjamin, Ph.D., Yi Chen, Ph.D. CFA, and Mark Breidenbach, Ph.D. have initiated coverage on Heat Biologics, Inc. (NASDAQ:HTBX) with a Buy, Price Target $13.00. The report is now available for viewing at the following link: Click here for complete report and disclosures .

About H.C. Wainwright & Co., LLC

H.C. Wainwright & Co., LLC is an investment bank dedicated to providing corporate finance, strategic advisory and related services to public and private growth companies across multiple sectors and regions. The H.C. Wainwright team has been the leader in the PIPE (private investment in public equity) and RD (registered direct offering) transaction markets. H.C. Wainwright was established in 1868 and is headquartered in New York City.

View source version on businesswire.com: http://www.businesswire.com/news/home/20150526006043/en/